Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1995
11/02/1995CA2188388A1 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
11/02/1995CA2188320A1 Compositions and methods for cell transformation
11/02/1995CA2188292A1 Contrast agents
11/02/1995CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995CA2187921A1 Dendrimeric compounds
11/02/1995CA2187323A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1110927A Medical polyacrylate pressure-sensitive adhesive and its prodn. method
11/01/1995CN1110913A Pharmaceutical composition
10/1995
10/31/1995US5463066 Liposome having a reactive oxycarbonylimidazole and polyether spacer chains; drug carriers
10/31/1995US5463039 Method of preparing hetero-branched cyclodextrins
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463022 N-acetylcarboxymethylchitosan derivatives and process for preparation thereof
10/31/1995US5463012 Polycarbonates and the use thereof for the preparation of bioerosible matrices
10/31/1995US5462990 Block copolymers with a non-binding polynonionic component and a water soluble polycationic portion for tissue binding; useful in inhibiting post-surgical adhesions
10/31/1995US5462976 Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
10/31/1995US5462951 Dissolved in a polyoxyethylene sorbitan fatty acid ester and adsorbed onto a porosity inorganic substance
10/31/1995US5462932 Aqueous, buffered alendronate solution containing a complexing agent to prevent precipitation; bone loss prevention
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462726 Suppressing vasoconstriction
10/31/1995CA2079325C Nutritional supplement containing vitamin e
10/31/1995CA2012194C Solid pharmaceutical composition containing nifedipine
10/31/1995CA2010037C Dual-action tablet
10/31/1995CA2001859C Sustained release drug-resin complexes
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028404A1 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use
10/26/1995WO1995028227A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995WO1995028158A1 Intranasal antimigraine composition
10/26/1995WO1995028150A1 Photocrosslinkable polyphosphazenes and their use as microencapsulation materials
10/26/1995WO1995028149A1 Controlled release biodegradable microspheres and method of preparation
10/26/1995DE4412464A1 New medicaments contg. steroid and antioxidant
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/26/1995CA2187768A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678525A1 Partially acylated beta-cyclodextrins
10/25/1995EP0678035A1 Vaccine preparations
10/25/1995EP0678034A1 Inducing cytotoxic t lymphocyte responses
10/25/1995EP0678019A1 Enhanced solubility pharmaceutical solutions
10/25/1995EP0678018A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
10/25/1995EP0678016A1 Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/25/1995CN1110555A Medical silicon cream and its series products
10/24/1995US5461170 Diglyceride from branched and straight chain fatty acids
10/24/1995US5461068 Imidazole derivative tincture and method of manufacture
10/24/1995US5461031 Monomeric insulin analog formulations
10/24/1995US5461030 Compositions and methods for enhancing wound healing
10/24/1995US5460831 Targeted transfection nanoparticles
10/24/1995US5460830 Biochemically active agents for chemical catalysis and cell receptor activation
10/24/1995US5460826 Morphine therapy
10/24/1995US5460821 Molecular transdermal transport system
10/24/1995CA1337451C Polyamide powder particles with a "desert rose" structure- process for preparing said polyamide powder
10/24/1995CA1337446C Pan emulsion
10/24/1995CA1337401C Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/24/1995CA1337399C Ibuprofen taste-masking process
10/23/1995CA2147020A1 Processing aid and product enhancer
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027732A2 Circularly permuted ligands and circularly permuted chimeric molecules
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027492A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995WO1995027481A1 Liquid delivery compositions
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2187185A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/18/1995EP0677322A2 Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
10/18/1995EP0677295A1 Liposome having oligosaccharide on the surface
10/18/1995EP0677126A1 Antiviral topical pharmaceutical compositions
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0676967A1 Readily available konjac glucomannan sustained release excipient
10/18/1995EP0676962A1 Enhanced pharmaceutical compositions for skin penetration
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0676953A1 Plasticized bioerodible controlled delivery system
10/18/1995EP0676952A1 Bioerodible controlled delivery system
10/18/1995EP0576478B1 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a
10/18/1995EP0533799B1 Compositions and methods for the controlled release of soluble active substances
10/18/1995EP0356435B1 Anti-inflammatory compounds and compositions
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110275A Inclusion complex of vitamin D and hydroxy propyl-Beta-cyclodextrin
10/18/1995CN1110179A Auxiliary material-oligosaccharlde for oral drug or solid drink
10/18/1995CN1110135A Pharmaceutical composition for controlled release
10/18/1995CN1110134A Liposome preparing technology and preparation thereof
10/18/1995CN1030038C Method for preparation of medicament by using carrot as auxiliary material
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459157 Pharmaceutical composition for ophthalmic use comprising a nonsteroidal anti-inflammatory and a decongestant drug
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5458881 N-acylated derivatives of mixtures of amino acids derived from hydrolysates of cereal proteins and their applications
10/17/1995US5458879 Oral vehicle compositions
10/17/1995US5458873 Carboxyvinyl polymer having Newtonian viscosity
10/17/1995US5458870 Compositions for magnetic resonance imaging using a manganese oxalate
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337338C Inositoltriphosphate
10/16/1995CA2121454A1 Inhibition, control and regression of angiogenesis
10/12/1995WO1995027075A1 Biological markers of benign prostate hyperplasia
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy